{
 "as_of": "2026-11-06",
 "cmr": "dk-cm-kg/XCSE/DK0011048619",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# BioPorto A/S (Nasdaq Copenhagen: DK0011048619) — research page\n\nAs of 2026-11-06 · dk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is BioPorto A/S, listed on Nasdaq Copenhagen, with ticker DK0011048619, ISIN DK0011048619 and LEI 5299004SWFL5JAN4W830. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 21 filings across 18 filing days in the twelve months to 2026-11-06. The median gap between filing days is 8 days. The latest filing is dated 2026-09-28, is of type Investor News, and is 39 days before the record date. The median gap for Nasdaq Copenhagen is 8.0 days, the median filings per issuer is 25, and the median latency is 4.0 days; the sector median is not on the record.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag is not set; the issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/dk/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 3 research houses: DNB Carnegie, HC Andersen Capital and H.C. Wainwright & Co.\n\n## Open research\n\nThe record holds 2 openly published research notes: H.C. Wainwright & Co. dated 2024-02-23, and HC Andersen Capital dated 2023-11-24.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is on the record for the market, and the live record start is not on the record.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.dk-cm-kg.ai/events/XCSE/DK0011048619 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterCPH|FirstNorthInformationCPH (the halt flag)\n- https://dk.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://bioporto.com/investor-relations/analyst/ (coverage)\n- https://bioporto.com/wp-content/uploads/2024/02/HCWainright-23022024.pdf (open research)\n- https://bioporto.com/wp-content/uploads/2024/02/HCA-Research-Report-on-Bioporto-24.11.23.pdf (open research)\n- https://mcp.dk-cm-kg.ai/record/XCSE/DK0011048619 (the record)\n",
 "market": "DK",
 "node": "dk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the DK vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "DK",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "DK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "DK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "dk-cm-kg/XCSE/DK0011048619",
  "coverage": {
   "count": 3,
   "houses": [
    {
     "analyst": "Oliver Røst Benneballe",
     "house": "DNB Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://bioporto.com/investor-relations/analyst/",
     "state": "sourced"
    },
    {
     "analyst": "Michael Friis",
     "house": "HC Andersen Capital",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://bioporto.com/investor-relations/analyst/",
     "state": "sourced"
    },
    {
     "analyst": "Yi Chen",
     "house": "H.C. Wainwright & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://bioporto.com/investor-relations/analyst/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://bioporto.com/investor-relations/analyst/",
     "result": "read: 3 of 6 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 119,
     "median_cadence_gap_days": 8,
     "median_filings": 25,
     "median_latency_days": 4,
     "name": "Nasdaq Copenhagen"
    },
    "sector": {
     "market": "DK",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual Financial Report": 1,
    "Changes board/management/auditors": 2,
    "Decisions of general meeting": 1,
    "Half Year financial report": 1,
    "Inside information": 6,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 1,
    "Major shareholder announcements": 1,
    "Managers' Transactions": 1,
    "Notice to general meeting": 1,
    "Other information disclosed according to the rules of the Exchange": 3,
    "Total number of voting rights and capital": 1
   },
   "cadence_median_gap_days": 8,
   "filing_days": 18,
   "filings": 21,
   "latency_days": 39,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-09-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b134c4cc1a56fbbd23bc139e112889a55&lang=en&src=listed",
     "title": "Unlocking the Growth - Invitation to BioPorto's investor meeting on October 7 ",
     "type": "Investor News"
    },
    {
     "category": "Half Year financial report",
     "date": "2026-08-20",
     "source": "https://view.news.eu.nasdaq.com/view?id=bd060a7aa12608bce6487e41e3def5d44&lang=en&src=listed",
     "title": "BioPorto announces Interim Results for the Second Quarter and First half of 2026",
     "type": "Half Year financial report"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-06-15",
     "source": "https://view.news.eu.nasdaq.com/view?id=b4252ef0968f2a129621e677022a11164&lang=en&src=listed",
     "title": "Grant of Warrants",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Inside information",
     "date": "2026-06-09",
     "source": "https://view.news.eu.nasdaq.com/view?id=b5a704d55654c9f59a81e7230dc2f819e&lang=en&src=listed",
     "title": "BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback",
     "type": "Inside information"
    },
    {
     "category": "Interim report (Q1 and Q3)",
     "date": "2026-05-21",
     "source": "https://view.news.eu.nasdaq.com/view?id=b626d0bf2931af6bc8968ca64d3afdec2&lang=en&src=listed",
     "title": "BioPorto announces Interim Result for the First Quarter of 2026",
     "type": "Interim report (Q1 and Q3)"
    }
   ],
   "latest_filing_date": "2026-09-28",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.dk-cm-kg.ai/events/XCSE/DK0011048619",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/dk roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Nasdaq Copenhagen"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/dk roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "DK0011048619"
   },
   "jurisdiction": {
    "market": "DK",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN DK0011048619)",
    "state": "sourced",
    "value": "5299004SWFL5JAN4W830"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/dk roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "BioPorto A/S"
   },
   "sector": {
    "market": "DK",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "DK",
    "state": "not_on_record"
   },
   "segment": {
    "market": "DK",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/dk roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "DK0011048619"
   },
   "website": {
    "market": "DK",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "DK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "DK",
  "node": "dk-cm-kg",
  "numbers_hash": "sha256:7c21c4fc5f7cee88e988139b0f4456445fb45b0ce598a1441ea9c085496b8af1",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2024-02-23",
     "kind": "independent",
     "publisher": "H.C. Wainwright & Co.",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://bioporto.com/wp-content/uploads/2024/02/HCWainright-23022024.pdf",
     "state": "sourced",
     "title": "BioPorto A/S (BIOPOR.CO) Rating: Buy"
    },
    {
     "date": "2023-11-24",
     "kind": "issuer-sponsored",
     "publisher": "HC Andersen Capital",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://bioporto.com/wp-content/uploads/2024/02/HCA-Research-Report-on-Bioporto-24.11.23.pdf",
     "state": "sourced",
     "title": "Company Name - Bioporto"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://dk.eu-cm-kg.ai/book/aio.json",
    "door": "https://dk.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/dk/mifid-ii-product-governance/r1",
   "section": "dk.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.dk-cm-kg.ai/record/XCSE/DK0011048619",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterCPH|FirstNorthInformationCPH",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:7c21c4fc5f7cee88e988139b0f4456445fb45b0ce598a1441ea9c085496b8af1",
 "path": "/dk/XCSE/DK0011048619",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is BioPorto A/S, listed on Nasdaq Copenhagen, with ticker DK0011048619, ISIN DK0011048619 and LEI 5299004SWFL5JAN4W830. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 21 filings across 18 filing days in the twelve months to 2026-11-06. The median gap between filing days is 8 days. The latest filing is dated 2026-09-28, is of type Investor News, and is 39 days before the record date. The median gap for Nasdaq Copenhagen is 8.0 days, the median filings per issuer is 25, and the median latency is 4.0 days; the sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The halt flag is not set; the issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/dk/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 3 research houses: DNB Carnegie, HC Andersen Capital and H.C. Wainwright & Co.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 2 openly published research notes: H.C. Wainwright & Co. dated 2024-02-23, and HC Andersen Capital dated 2023-11-24.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is on the record for the market, and the live record start is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.dk-cm-kg.ai/events/XCSE/DK0011048619"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterCPH|FirstNorthInformationCPH"
  },
  {
   "for": "the orderability chapter",
   "source": "https://dk.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://bioporto.com/investor-relations/analyst/"
  },
  {
   "for": "open research",
   "source": "https://bioporto.com/wp-content/uploads/2024/02/HCWainright-23022024.pdf"
  },
  {
   "for": "open research",
   "source": "https://bioporto.com/wp-content/uploads/2024/02/HCA-Research-Report-on-Bioporto-24.11.23.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.dk-cm-kg.ai/record/XCSE/DK0011048619"
  }
 ],
 "title": "BioPorto A/S (DK0011048619) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}